Youn‐Jae Lee

Twenty‐four‐week clevudine therapy showed potent and sustained antiviral activity in HBeAg‐positive chronic hepatitis B†‡

Byung Chul Yoo, Ju Hyun Kim, Young–Hwa Chung et al. · Hepatology · 2007 · 134 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

All‐oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub‐analysis in Asian patients from the <scp>HALLMARK DUAL</scp> study

Jia‐Horng Kao, Youn‐Jae Lee, Jeong Heo et al. · Liver International · 2016 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Daclatasvir/asunaprevir/beclabuvir, all‐oral, fixed‐dose combination for patients with chronic hepatitis C virus genotype 1

Jia‐Horng Kao, Ming‐Lung Yu, Jeong Heo et al. · Journal of Gastroenterology and Hepatology · 2017 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Daclatasvir plus asunaprevir for <scp>HCV</scp> genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis

Jia‐Horng Kao, Donald M. Jensen, Michael P. Manns et al. · Liver International · 2015 · 16 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Serum HBsAg levels during peginterferon α‐2a treatment with or without thymosin α‐1 in HBeAg‐positive chronic hepatitis B patients

Eun Young Song, Yunsu Shin, Eun Youn Roh et al. · Journal of Medical Virology · 2010 · 12 citations

Pharmacy, Immunology, Infectious Diseases +17